Kinetics of Wound Development and Healing Suggests a Skin-Stabilizing Effect of Allogeneic ABCB5
ABCB5
cell therapy
mesenchymal stromal cells
recessive dystrophic epidermolysis bullosa
wound healing
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
24 May 2023
24 May 2023
Historique:
received:
02
05
2023
revised:
19
05
2023
accepted:
23
05
2023
medline:
12
6
2023
pubmed:
10
6
2023
entrez:
10
6
2023
Statut:
epublish
Résumé
Recessive dystrophic epidermolysis (RDEB) is a rare, inherited, and currently incurable skin blistering disorder characterized by cyclically recurring wounds coexisting with chronic non-healing wounds. In a recent clinical trial, three intravenous infusions of skin-derived ABCB5
Identifiants
pubmed: 37296590
pii: cells12111468
doi: 10.3390/cells12111468
pmc: PMC10252830
pii:
doi:
Substances chimiques
Collagen Type VII
0
ABCB5 protein, human
0
ATP Binding Cassette Transporter, Subfamily B
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NHLBI NIH HHS
ID : 1R01HL161087
Pays : United States
Organisme : NIA NIH HHS
ID : 1P01AG071463
Pays : United States
Organisme : NEI NIH HHS
ID : R24 EY028767
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY025794
Pays : United States
Organisme : NEI NIH HHS
ID : RO1EY025794
Pays : United States
Organisme : NIA NIH HHS
ID : P01 AG071463
Pays : United States
Organisme : NEI NIH HHS
ID : R24EY028767
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL161087
Pays : United States
Références
J Clin Med. 2021 Dec 13;10(24):
pubmed: 34945131
Am J Clin Dermatol. 2010;11 Suppl 1:53-4
pubmed: 20586512
EMBO Mol Med. 2021 Oct 7;13(10):e14864
pubmed: 34515407
Cell Rep. 2015 Sep 8;12(10):1564-74
pubmed: 26321644
J Am Acad Dermatol. 2021 Nov;85(5):1296-1298
pubmed: 32896597
J Invest Dermatol. 2015 Sep;135(9):2319-2321
pubmed: 25905587
Orphanet J Rare Dis. 2021 Apr 13;16(1):175
pubmed: 33849616
Cytotherapy. 2019 May;21(5):546-560
pubmed: 30878384
Int J Mol Sci. 2022 Dec 21;24(1):
pubmed: 36613507
J Invest Dermatol. 2022 Jun;142(6):1725-1736.e10
pubmed: 34808236
Stem Cells. 2019 Aug;37(8):1057-1074
pubmed: 31002437
Br J Dermatol. 2022 Apr;186(4):609-619
pubmed: 34862606
J Clin Invest. 2008 May;118(5):1669-79
pubmed: 18382769
JCI Insight. 2021 Jan 25;6(2):
pubmed: 33491668
Acta Derm Venereol. 2020 Feb 6;100(5):adv00053
pubmed: 32039456
Dermatol Clin. 2010 Jan;28(1):93-105
pubmed: 19945621
Pediatr Rheumatol Online J. 2011 Jun 27;9:13
pubmed: 21707991
Orphanet J Rare Dis. 2022 Aug 13;17(1):314
pubmed: 35964087
Cytotherapy. 2023 Jul;25(7):782-788
pubmed: 36868990
Aging (Albany NY). 2015 Jun;7(6):389-411
pubmed: 26143532
J Am Acad Dermatol. 2020 Aug;83(2):447-454
pubmed: 31786163
Stem Cells. 2017 Jun;35(6):1446-1460
pubmed: 28316123
Dermatol Ther (Heidelb). 2021 Aug;11(4):1175-1197
pubmed: 34110606
iScience. 2019 May 31;15:421-438
pubmed: 31121468
Orphanet J Rare Dis. 2020 Oct 19;15(1):292
pubmed: 33076941
Stem Cell Res Ther. 2022 Sep 5;13(1):455
pubmed: 36064604
Mol Ther. 2015 Aug;23(8):1368-1379
pubmed: 25858020
JID Innov. 2022 Jan;2(1):
pubmed: 34870260
Int J Mol Sci. 2021 May 12;22(10):
pubmed: 34065916
EMBO Mol Med. 2015 Jul 20;7(9):1211-28
pubmed: 26194911
Stem Cells. 2016 Sep;34(9):2393-406
pubmed: 27299700
EMBO Mol Med. 2021 Oct 7;13(10):e14392
pubmed: 34459121
Orphanet J Rare Dis. 2020 Jan 3;15(1):1
pubmed: 31900176
JCI Insight. 2021 Nov 22;6(22):
pubmed: 34665781
Lab Invest. 2017 Oct;97(10):1218-1224
pubmed: 28892093
Cytotherapy. 2021 Feb;23(2):165-175
pubmed: 33011075
Stem Cells. 2021 Jul;39(7):897-903
pubmed: 33609408
Front Genet. 2021 Sep 28;12:737272
pubmed: 34650598
Stem Cell Res Ther. 2020 Nov 16;11(1):482
pubmed: 33198791